Hepatitis C

Sofosbuvir/Ravidasvir Combination Therapy Phase II/III

NCT02961426  |  Malaysia, Thailand 

This is a multicentre, multi-country, trial to assess the efficacy, safety, tolerance, and pharmacokinetics of sofosbuvir plus ravidasvir for the treatment of HCV infection.

 

Ravidasvir Phase I

NCT03602300 |  Malaysia  

Open-label, crossover study to evaluate the relative bioavailability of a tablet formulation of ravidasvir versus the capsule formulation of ravidasvir in healthy adult subjects.

 

Last update: September 2018